For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT05812807?term=a012103&limit=10&sort=@relevance&rank=1
A012103: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy with Checkpoint Inhibitor Therapy (OptimICE-PCR)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Breast
Study Status:
Open to Accrual
Principal investigator:
Robert Donegan, MD
IRB number :
2355831
Study Number:
A012103
Phone:
Fax:
A012301: LoTam: A Randomized, Phase III Clinical Trial of Low-Dose Tamoxifen for Selected Patients with Molecular Low-Risk Early-Stage Breast Cancer
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Breast
Study Status:
Open to Accrual
Principal investigator:
Dongyan Liu, MD
IRB number :
2391476
Study Number:
A012301
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT06671912?term=lotam&limit=10&sort=@relevance&rank=1
A012303: Shortened Duration of Adjuvant Therapy in Patients with Early-Stage HER2+ Breast Cancer who Achieve pCR After Neoadjuvant Chemotherapy with HER2 Blockade (ShortStop-Her2)
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Breast
Study Status:
Open to Accrual
Principal investigator:
Zhuoyan Li, MD
IRB number :
2365021
Study Number:
A012303
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT06876714?term=a012303&limit=10&sort=@relevance&rank=1
A031702: A phase II study of Ipilimumab, CabOzantinib, and NIvolumab in rare genitourinary Cancers
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Genitourinary
Study Status:
Open to Accrual
Principal investigator:
Paul Celano, MD
IRB number :
1857033
Study Number:
A031702
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT03866382
A081801: Integration of Immunotherapy Into Adjuvant Therapy for Resected NSCLC: ALCHEMIST Chemo-IO
Contact Name:
Laura Morse Cucci
Study Type:
Oncology - Pulmonary
Study Status:
Open to Accrual
Principal investigator:
Mei Tang, MD
IRB number :
1628769
Study Number:
A081801
Phone:
Fax:
For more information about this clinical trial, please visit the following link: https://clinicaltrials.gov/study/NCT04267848?term=a081801&rank=2